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The etiology of the rheumatoid fac-
tors in patients with rheumatoid ar-
thritis and of anti-globulin antibodies 
in normal individuals remains obscure 
despite recently documented observa-
tions. Allen and Kunkel (1963) and 
Vierucci (1965) have reported an in-
creased incidence of anti-globulin 
antibodies in children who received 
multiple transfusions for chronic ane-
mia. Fudenberg et al. (1964) and 
Stiehm (1965) found that children who 
had been receiving repeated y-globulin 
injections were more prone to produce 
anti-globulin antibodies than children 
not exposed to y-globulin. These data 
furnish indirect evidence of the iso-
antigenicity of genetic determinants in 
human y-globulin. From the clinical 
standpoint, the observations are of in-
terest to pediatricians administering 
y-globulin to children whose sera show 
low levels of y-globulin, and whose 
clinical courses are characterized by 
repeated or chronic infections. 
This study was undertaken to de-
termine the incidence of anti-globulin 
antibodies in non-hospitalized children 
with chronic or recurrent upper re-
spiratory infections, only some of 
whom had received y-globulin injec-
tions. 
Materials and Methods 
The 185 children studied were under 
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the care of their private physicians or 
attended the pediatric clinic. Hospital 
patients were not included. With the 
cooperation of the participating physi-
cians, history forms were completed on 
each child, recording age, race, sex, 
the amount and duration of globulin 
therapy, reason for administering y-
globulin, transfusion history, and 
whether or not joint symptoms were 
present. All children with a transfusion 
history were excluded from this study 
in order to obtain a more uniform 
population. 
The 44 children who had received 
y-globulin injections had y-globulin 
levels less than 500 mg per 100 ml. 
The duration of y-globulin therapy re-
flected to some degree the course and 
duration of their respiratory infections. 
The 141 children who had "never" re-
received any y-globulin comprised the 
largest group. Although these children 
were recorded as "never" having had 
y-globulin, it has been customary for 
some physicians to give a small amount 
of y-globulin with measles vaccine. 
Some of these 141 children were tested 
before the initiation of y-globulin 
therapy. Thus, these children do not 
necessarily represent a group of chil-
dren with normal levels of y-globulin. 
All sera were tested at a 1 : 20 dilu-
tion by: the slide latex test (Hyland), 
the sensitized human cell test, and the 
sensitized sheep cell test. These tests 
have been described previously (Waller 
et al., 1961). In addition, most of the 
sera were tested at a 1 : 5 dilution with 
selected sensitized cells known to de-
tect anti-Gm", Gm", Gmx and Gm' 
activity. 
Results 
Anti-globulin Antibodies 
Of the 185 children studied, only 44 
had received injections of y-globulin 
at the time of testing. All of these chil-
dren were tested at a 1 : 20 dilution of 
their serum with the slide latex test 
and the sensitized human cell test. The 
latex test was strongly reactive in only 
one child and weakly reactive in 12 
children. Only one of these 13 children 
had received y-globulin injections. The 
human cell test was positive in eight 
children ( 4.3 % ), only one of whom had 
received y-globulin. This incidence does 
not differ significantly from that char-
acteristic of the normal adult popula-
tion (Waller et al. , 1964). The sensi-
tized sheep cell test (Waaler-Rose 
Test) was performed on 135 children, 
including all children found to be posi-
tive by any of the other tests. In no 
instance was a positive sheep cell test 
observed. 
Since the titers of anti-globulin anti-
bodies in normal individuals may often 
fall below 1 : 20, 140 of the original 
185 children were tested at 1 : 5 dilu-
tion of their serum with Ripley sensi-
tized cells. Eighteen children (12.9 % ) 
gave positive tests at this dilution. How-
ever, of these 18 children with positive 
tests, only three had received injections 
of y-globulin. 
Thus, to look at the results in an-
other way, of the 108 children who had 
not received injections of y-globulin 
and whose sera were tested at a 1 : 5 
dilution, 15 (13.9 %) gave positive 
tests. However, of the 32 children who 
had received y-globulin and whose 
sera were tested at a 1 : 5 dilution, only 
three (9.4%) gave positive tests. These 
differences are probably not statisti-
cally significant (p > .4). 
Figure 1 compares the titers of anti-
globulin antibodies in children who 
had received y-globulin injections with 
those who had not received any y-
globulin. The left bars, 1 : 5, represent 
the negative group in our study, since 
the children were not tested at a level 
below 1: 5. Ten children gave titers of 
1 :5, but only two of these had had 
y-globulin. Eight children had titers 
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Fig. 1-Titers of anti-globulin antibodies in 32 children who had received '}'-globulin 
injections, and 108 who had not. 
above 1 :5, but only one child had had 
y-globulin. Thus, among the 44 chil-
dren who had received injections of 
y-globulin, only three children gave 
positive tests for anti-globulin anti-
bodies. There was no correlation be-
tween the amount of y-globulin ad-
ministered , the duration of globulin 
therapy, and the presence of a posi-
tive test for anti-globulin antibodies . 
Three children had had in excess of 
100 m l of y-globulin over a period 
from one to three years, and all gave 
negative tests at 1 : 20 dilution of their 
serum. Two of the three were also 
negative at 1 : 5 dilution of their serum. 
Gm Specificity of Anti-globulin 
Antibodies 
In addition to the sensitized human 
cell test (Ripley), four other anti-D 
sera were used to sensitize cells for Gm 
specificity of the children's sera. Ninety 
children were tested for Gm specificity. 
Of these 90 children, 10 agglutinated 
the Ripley sensitized cells and five of 
the 10 agglutinated one or more of 
the other sensitized cells. Of these 10 
children, five gave specific anti-Gm 
activity, one anti-Gm(f), one anti-
Gm(x) , and three anti-Gm(a). The 
sera of the other five children agglu-
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tinated only the Ripley sensitized cells, 
and it was not possible to obtain Gm 
specificity. Of the five children whose 
sera showed specific anti-Gm activity, 
only one had received y-globulin. 
Lack of Correlation between Pres-
ence of Anti-globulin Antibodies and 
Level of y-globulin or Age of Chil-
dren 
There was no apparent correlation 
between the presence of hypogamma-
globulinemia (<500 mg per 100 ml) 
and the presence of anti-globulin anti-
body. There was also no correlation 
between the ages of the children and 
the presence of anti-globulin antibody. 
Among the children up to three years 
of age, 12% gave positive tests for 
anti-globulin antibody at a 1 : 5 dilu-
tion of their sera. Among the children 
over three years of age, 13.7 % gave 
positive tests. Of the 185 children 
studied, four children gave history of 
joint complaints, none had had y-glob-
ulin at the time of the study, and none 
had anti-globulin antibodies demon-
strable in their sera. 
Injection of y-Globulin into Adults 
We have studied the effects of sub-
cutaneous injections of pooled y-globu-
lin in four young healthy male vol-
unteers. These men were all Gm(a-) 
and received (.5 ml) injections of pooled 
y-globulin weekly. In addition to tests 
for anti-globulin antibodies, slide latex 
tests, and sensitized sheep cell tests, the 
followi ng tests were performed: serum 
electrophoretic pattern, sedimentation 
rate, hemoglobin , and total protein. 
Two of the volunteers received a 
total of eight injections of y-globulin 
over a period of three months and two 
received 16 injections over a period of 
one year. In no instance did these four 
individuals produce anti-globulin anti-
bodies, nor were any changes noted in 
the other tests performed. 
Discussion 
Although the incidence of anti-glob-
ulin antibodies in children receiving 
multiple transfusions is markedly in-
creased, we were not able to demon-
strate this increased incidence in the 
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children receiving pooled y-globulin. 
There are several possible explanations 
for these observed differences. The 
children receiving multiple transfusions 
had a definite disease entity while the 
children that we studied were "normal" 
except for chronic or recurrent upper 
respiratory infections. The evaluation 
of just how chronic, recurrent, or se-
vere the infection rested with the in-
dividual physician; however, all of the 
children studied had electrophoretic 
patterns of their serum performed as 
a consequence of the degree or dura-
tion of their infection. No attempt was 
made in this study to separate the 
children according to degree or dura-
tion of their illnesses. Certainly, the 
children were not ill enough to require 
hospitalization during the period of 
this study. 
It is possible that plasma is more 
antigenic than pooled y-globulin or 
that the globulin administered intra-
venously is a better antigen than when 
it is administered intramuscularly. In 
addition, the children receiving multi-
ple transfusions received more plasma 
for a longer period of time than did 
the children receiving pooled y-globu-
lin. 
Stiehm and Fudenberg (1965) stud-
ied 14 hypogammaglobulinemic chil-
dren who had received many y-globu-
lin injections and found that nine of 
these children (64.3 % ) had developed 
anti-globulin antibodies. Among the 
24 untreated siblings of these children, 
only two agglutinators were found 
(8 .3% ). We are not able to explain the 
discrepancies in these results other 
than by the fact that we did not use as 
controls the siblings of the hypogam-
maglobulinemic children. However, in 
addition , one may presume that the 
untreated siblings were untreated be-
cause they were not hypogamma-
globulinemic or that they were not 
subject to chronic or recurrent infec-
tion. Some of our untreated children 
were hypogammaglobulinemic and 
most were subject to chronic infection. 
After the testing of their sera, some 
children were started on y-globulin 
therapy. 
Since an equal number of our chil-
dren who had not received y-globulin 
produced anti-globulin antibodies, pre-
sumably other, as yet unknown, agents 
are as likely to stimulate the produc-
tion of these antibodies as is the ad-
ministration of pooled y-globulin. 
Steinberg and Wilson (1963) studied 
eight non-transfused donors of y-
globulin antibodies and found that in 
each instance the donor's mother had 
the globulin factor that the donor 
lacked. They assumed that the donor's 
antibody was formed as a result of 
transplacental isoimmunization. How-
ever, we have been unsuccessful in our 
attempts to elicit anti-globulin anti-
bodies in normal adult Gm(a-) volun-
teers by the injection of pooled y-
globulin. 
There is no definitive evidence that 
the serological reactions called rheu-
matoid factors in patients with rheu-
matoid arthritis and anti-globulin anti-
bodies in normal individuals, differ 
except in strength of reaction (titer) 
and possibly in specificity. Not all in-
vestigators are convinced that the idea 
of an antigen-antibody relationship for 
y-globulin (Gm) and anti-globulin re-
agents (anti-Gm) in man is firmly es-
tablished (Grubb, 1961). Certainly, 
the deleterious effects of the serologi-
cal reactions called "rheumatoid fac-
tors" have not been proven at the 
present time. Regardless of these unre-
solved questions, it is not established 
that the isoantigenicity of y-globulin 
is such as to override its therapeutic 
potential in infection. 
Summary 
1. We examined sera from 185 non-
hospitalized children, 44 of whom had 
received repeated injections of y-glob-
ulin for upper respiratory infections. 
2. There was no significant differ-
ence in the incidence of anti-globulin 
antibodies in the two groups. 
3. The presence of anti-globulin 
antibodies could not be correlated with 
the level of y-globulin in the children's 
sera or with the age of the children. 
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